SCOPUS 정보 검색 플랫폼

Volumn 55, Issue 2, 2011, Pages 276-277

Fighting the bushfire in HCC trials

(8) Schirmacher, Peter a Bedossa, Pierre b Roskams, Tania c Tiniakos, Dina G d Brunt, Elizabeth M e Zucman Rossi, Jessica f Manns, Michael P g Galle, Peter R h

a UNIVERSITY HOSPITAL HEIDELBERG (Germany)

b BEAUJON HOSPITAL (France)

c UNIVERSITY OF LEUVEN (Belgium)

d UNIVERSITY OF ATHENS (Greece)

e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (United States)

f Université Paris 13 (France)

g HANNOVER MEDICAL SCHOOL (Germany)

h JOHANNES GUTENBERG UNIVERSITY (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SORAFENIB; SUNITINIB;

CANCER IMMUNOTHERAPY; CANCER PALLIATIVE THERAPY; DRUG INDUSTRY; DRUG RESEARCH; EDITORIAL; HEALTH CARE COST; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMIC THERAPY;

BIOPSY; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIALS AS TOPIC; HUMANS; LIVER NEOPLASMS;

EID: 79959311213 PISSN: 01688278 EISSN: None Source Type: Journal
DOI: 10.1016/j.jhep.2011.03.004 Document Type: Editorial

Times cited : (18)

References (9)

1
- 47949116252
- Sorafenib in advanced hepatocellular carcinoma
- J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 4 2008 378 390
- (2008) N Engl J Med , vol.359 , Issue.4 , pp. 378-390
- Llovet, J.M.¹ Ricci, S.² Mazzaferro, V.³ Hilgard, P.⁴ Gane, E.⁵ Blanc, J.F.⁶

2
- 28844480321
- Practice Guidelines Committee, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma
- J. Bruix, and M. Sherman Practice Guidelines Committee, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma Hepatology 42 5 2005 1208 1236
- (2005) Hepatology , vol.42 , Issue.5 , pp. 1208-1236
- Bruix, J.¹ Sherman, M.²

3
- 79960448307
- Pfizer press release 4/23/2010
- Pfizer press release 4/23/2010.

4
- 77955551055
- American Society of Clinical Oncology American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer
- H.J. Burstein, A.A. Prestrud, J. Seidenfeld, H. Anderson, T.A. Buchholz, and N.E. Davidson American Society of Clinical Oncology American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer J Clin Oncol 28 23 2010 3784 3796
- (2010) J Clin Oncol , vol.28 , Issue.23 , pp. 3784-3796
- Burstein, H.J.¹ Prestrud, A.A.² Seidenfeld, J.³ Anderson, H.⁴ Buchholz, T.A.⁵ Davidson, N.E.⁶

5
- 67650652432
- I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy
- A.D. Barker, C.C. Sigman, G.J. Kelloff, N.M. Hylton, D.A. Berry, and L.J. Esserman I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy Clin Pharmacol Ther 86 1 2009 97 100
- (2009) Clin Pharmacol Ther , vol.86 , Issue.1 , pp. 97-100
- Barker, A.D.¹ Sigman, C.C.² Kelloff, G.J.³ Hylton, N.M.⁴ Berry, D.A.⁵ Esserman, L.J.⁶

6
- 33748435058
- DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
- DOI 10.1056/NEJMoa060570
- K.A. Olaussen, A. Dunant, P. Fouret, E. Brambilla, F. André, and V. Haddad IALT Bio Investigators. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 10 2006 983 991 (Pubitemid 44343542)
- (2006) New England Journal of Medicine , vol.355 , Issue.10 , pp. 983-991
- Olaussen, K.A.¹ Dunant, A.² Fouret, P.³ Brambilla, E.⁴ Andre, F.⁵ Haddad, V.⁶ Taranchon, E.⁷ Filipits, M.⁸ Pirker, R.⁹ Popper, H.H.¹⁰ Stahel, R.¹¹ Sabatier, L.¹² Pignon, J.-P.¹³ Tursz, T.¹⁴ Le Chevalier, T.¹⁵ Soria, J.-C.¹⁶

7
- 33846463379
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
- DOI 10.1002/hep.21467
- S. Boyault, D.S. Rickman, A. de Reynis, C. Balabaud, S. Rebouissou, and E. Jeannot Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 1 2007 42 52 (Pubitemid 46144363)
- (2007) Hepatology , vol.45 , Issue.1 , pp. 42-52
- Boyault, S.¹ Rickman, D.S.² De Reynies, A.³ Balabaud, C.⁴ Rebouissou, S.⁵ Jeannot, E.⁶ Herault, A.⁷ Saric, J.⁸ Belghiti, J.⁹ Franco, D.¹⁰ Bioulac-Sage, P.¹¹ Laurent-Puig, P.¹² Zucman-Rossi, J.¹³

8
- 35648950024
- Genetically Distinct and Clinically Relevant Classification of Hepatocellular Carcinoma: Putative Therapeutic Targets
- DOI 10.1053/j.gastro.2007.08.038, PII S0016508507014941
- H. Katoh, H. Ojima, A. Kokubu, S. Saito, T. Kondo, and T. Kosuge Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets Gastroenterology 133 5 2007 1475 1486 (Pubitemid 350029748)
- (2007) Gastroenterology , vol.133 , Issue.5 , pp. 1475-1486
- Katoh, H.¹ Ojima, H.² Kokubu, A.³ Saito, S.⁴ Kondo, T.⁵ Kosuge, T.⁶ Hosoda, F.⁷ Imoto, I.⁸ Inazawa, J.⁹ Hirohashi, S.¹⁰ Shibata, T.¹¹

9
- 57349090407
- Gene expression in fixed tissues and outcome in hepatocellular carcinoma
- Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.Y. Chiang, and A. Camargo Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 19 2008 1995 2004
- (2008) N Engl J Med , vol.359 , Issue.19 , pp. 1995-2004
- Hoshida, Y.¹ Villanueva, A.² Kobayashi, M.³ Peix, J.⁴ Chiang, D.Y.⁵ Camargo, A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.